A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

StatusCompleted
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of the study is to learn what happens to different doses and forms of TERN-701 in a healthy person's body over time. Researchers will compare what happens to different doses and forms of TERN-701 in a person's body over time when given with or without food, or with or without other medications. The goal of the study is to learn: * What happens to different doses of TERN-701 in a person's body over time when it is given with or without food, or with or without other medications. * About the safety of TERN-701 and if people tolerate it
Trial Details
NCT Number NCT07838987
Lead Sponsor Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Conditions
(from sponsor)		 Healthy
Enrollment 196 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov